1. GPCR/G Protein Immunology/Inflammation
  2. CXCR
  3. YU241279

YU241279 是一种口服有效的 CXCR5 抑制剂。YU241279 可抑制表达 CXCR5 的细胞中由 CXCL13 介导的 Gαq 依赖性钙内流,以及 Gαi2 依赖性 cAMP 降低。YU241279 可抑制表达 CXCR5 的淋巴瘤细胞增殖。YU241279 可降低植入淋巴瘤组织的小鼠外周血和骨髓中的肿瘤负荷。YU241279 在小鼠口服给药期间具有耐受性,能维持稳定的血药浓度且代谢无变化。YU241279 可用于血管免疫母细胞性 T 细胞淋巴瘤和伯基特 B 细胞淋巴瘤的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

YU241279

YU241279 Chemical Structure

CAS No. : 1092445-63-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

YU241279 is an orally active CXCR5 inhibitor. YU241279 inhibits CXCL13-mediated Gαq-dependent calcium influx and Gαi2-dependent cAMP reduction in CXCR5-expressing cells. YU241279 inhibits the proliferation of CXCR5-expressing lymphoma cells. YU241279 reduces tumor burden in the peripheral blood and bone marrow of mice implanted with lymphoma tissues. YU241279 is well tolerated during oral administration in mice, maintains stable plasma drug concentrations, and shows no metabolic changes. YU241279 can be used in the research of angioimmunoblastic T-cell lymphoma and Burkitt B-cell lymphoma[1].

体外研究
(In Vitro)

YU241279 (compound 2) 可强效抑制稳定表达人 CXCR5 的分裂阻滞 HEK-293 细胞中 Gaq 介导的 Ca2+内流,在 HBSS 缓冲液中的 IC50 值为 166.4 nM,在 HBSS 缓冲液+1% BSA 中的 IC50 值为 444.4 nM[1]
YU241279 可强效抑制稳定表达人 CXCR5 的分裂阻滞 HEK-293 细胞中由 Gαi2 介导的 cAMP 降低,在 HBSS buffer 中的 IC50 值为 341.1 nM,在 HBSS buffer + 1% BSA 中的 IC50 值为 584.5 nM[1]
YU241279 (1-30 μM; 7 d) 呈剂量依赖性抑制表达 CXCR5 的 Raji 伯基特 B 细胞淋巴瘤细胞的增殖,在低至 1 μM 的浓度下即可观察到显著的抑制作用[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: CXCR5-expressing Raji Burkitt's B-cell lymphoma cells
Concentration: 1-30 μM
Incubation Time: 7 days
Result: Induced a dose-dependent decrease in Raji cell proliferation over 7 days.
Significantly reduced proliferation relative to DMSO control at 1 μM (p<0.01).
Significantly reduced proliferation relative to DMSO control at 3 μM, 10 μM, and 30 μM (p<0.005 for each).
体内研究
(In Vivo)

YU241279 (compound 2) (40 mg/kg;灌胃;每日 2 次;连续 42 天) 可在 NSG 小鼠中使 AITL 肿瘤负荷显著降低[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: NSG (NOD/SCID, IL-2R knockout; 8 animals per group)[1]
Dosage: 40 mg/kg
Administration: oral gavage; twice daily; 42 days
Result: Reduced absolute percentage of human CD45+ cells in bone marrow to 10.6%.
Reduced absolute percentage of human CD45+ cells in peripheral blood to 44.5%.
Maintained 5 surviving mice at study end.
分子量

351.44

Formula

C22H25NO3

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
YU241279
目录号:
HY-182774
需求量: